203 related articles for article (PubMed ID: 35862997)
1. A Fluorometric Assay for the
Arberas-Jiménez I; Rizo-Liendo A; Sifaoui I; Chao-Pellicer J; Piñero JE; Lorenzo-Morales J
Microbiol Spectr; 2022 Aug; 10(4):e0051522. PubMed ID: 35862997
[TBL] [Abstract][Full Text] [Related]
2. Studies on the cyst stage of Naegleria fowleri in vivo and in vitro.
Evdokiou A; Marciano-Cabral F; Jamerson M
J Eukaryot Microbiol; 2022 Mar; 69(2):e12881. PubMed ID: 34918439
[TBL] [Abstract][Full Text] [Related]
3. Natural Terpenes Inhibit the Cytopathogenicity of
Rajendran K; Ahmed U; Meunier AC; Shaikh MF; Siddiqui R; Anwar A
ACS Chem Neurosci; 2023 Dec; 14(23):4105-4114. PubMed ID: 37983556
[No Abstract] [Full Text] [Related]
4. Cyanomethyl Vinyl Ethers Against
Chao-Pellicer J; Arberas-Jiménez I; Delgado-Hernández S; Sifaoui I; Tejedor D; García-Tellado F; Piñero JE; Lorenzo-Morales J
ACS Chem Neurosci; 2023 Jun; 14(11):2123-2133. PubMed ID: 37167960
[No Abstract] [Full Text] [Related]
5. Oleic Acid Coated Silver Nanoparticles Showed Better
Rajendran K; Anwar A; Khan NA; Aslam Z; Raza Shah M; Siddiqui R
ACS Chem Neurosci; 2020 Aug; 11(16):2431-2437. PubMed ID: 31347828
[No Abstract] [Full Text] [Related]
6. Identification of cysteine protease inhibitors as new drug leads against Naegleria fowleri.
Zyserman I; Mondal D; Sarabia F; McKerrow JH; Roush WR; Debnath A
Exp Parasitol; 2018 May; 188():36-41. PubMed ID: 29551628
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Fatty Acid Oxidation as a New Target To Treat Primary Amoebic Meningoencephalitis.
Sarink MJ; Tielens AGM; Verbon A; Sutak R; van Hellemond JJ
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513800
[TBL] [Abstract][Full Text] [Related]
8. Fowlerstefin, a cysteine protease inhibitor of Naegleria fowleri, induces inflammatory responses in BV-2 microglial cells in vitro.
Thái TL; Kang JM; Lê HG; Lee J; Yoo WG; Shin HJ; Sohn WM; Na BK
Parasit Vectors; 2020 Jan; 13(1):41. PubMed ID: 31996242
[TBL] [Abstract][Full Text] [Related]
9. The anti-amoebic activity of Pinus densiflora leaf extract against the brain-eating amoeba Naegleria fowleri.
Lê HG; Kim W; Kang JM; Võ TC; Yoo WG; Cheong H; Na BK
Parasites Hosts Dis; 2024 May; 62(2):169-179. PubMed ID: 38835258
[TBL] [Abstract][Full Text] [Related]
10. The anti-amoebic potential of carboxamide derivatives containing sulfonyl or sulfamoyl moieties against brain-eating Naegleria fowleri.
Akbar N; Siddiqui R; El-Gamal MI; Zaraei SO; Alawfi BS; Khan NA
Parasitol Res; 2023 Nov; 122(11):2539-2548. PubMed ID: 37665414
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle-Terpene Fusion: A Game-Changer in Combating Primary Amoebic Meningoencephalitis Caused by
Rajendran K; Ahmed U; Meunier AC; Shaikh MF; Siddiqui R; Anwar A
ACS Omega; 2024 Mar; 9(10):11597-11607. PubMed ID: 38497026
[TBL] [Abstract][Full Text] [Related]
12. A case of Naegleria fowleri related primary amoebic meningoencephalitis in China diagnosed by next-generation sequencing.
Wang Q; Li J; Ji J; Yang L; Chen L; Zhou R; Yang Y; Zheng H; Yuan J; Li L; Bi Y; Gao GF; Ma J; Liu Y
BMC Infect Dis; 2018 Jul; 18(1):349. PubMed ID: 30055569
[TBL] [Abstract][Full Text] [Related]
13. Primary Amoebic Meningoencephalitis: Neurochemotaxis and Neurotropic Preferences of Naegleria fowleri.
Baig AM
ACS Chem Neurosci; 2016 Aug; 7(8):1026-9. PubMed ID: 27447543
[TBL] [Abstract][Full Text] [Related]
14. Primary Amoebic Meningoencephalitis by
Güémez A; García E
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572533
[No Abstract] [Full Text] [Related]
15. Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
Kim JH; Jung SY; Lee YJ; Song KJ; Kwon D; Kim K; Park S; Im KI; Shin HJ
Antimicrob Agents Chemother; 2008 Nov; 52(11):4010-6. PubMed ID: 18765686
[TBL] [Abstract][Full Text] [Related]
16. Isolation and molecular identification of Naegleria fowleri from Nile river, Egypt.
Al-Herrawy AZ; Gad MA
J Egypt Public Health Assoc; 2015 Dec; 90(4):161-5. PubMed ID: 26854897
[TBL] [Abstract][Full Text] [Related]
17. Cyclolauranes as plausible chemical scaffold against Naegleria fowleri.
Arberas-Jiménez I; García-Davis S; Rizo-Liendo A; Sifaoui I; Morales EQ; Piñero JE; Lorenzo-Morales J; Díaz-Marrero AR; Fernández JJ
Biomed Pharmacother; 2022 May; 149():112816. PubMed ID: 35286966
[TBL] [Abstract][Full Text] [Related]
18. Identification and significance of Naegleria fowleri isolated from the hot spring which related to the first primary amebic meningoencephalitis (PAM) patient in Taiwan.
Tung MC; Hsu BM; Tao CW; Lin WC; Tsai HF; Ji DD; Shen SM; Chen JS; Shih FC; Huang YL
Int J Parasitol; 2013 Aug; 43(9):691-6. PubMed ID: 23665128
[TBL] [Abstract][Full Text] [Related]
19. Exploring the Anti-Infective Value of Inuloxin A Isolated from
Zeouk I; Sifaoui I; Rizo-Liendo A; Arberas-Jiménez I; Reyes-Batlle M; L Bazzocchi I; Bekhti K; E Piñero J; Jiménez IA; Lorenzo-Morales J
ACS Chem Neurosci; 2021 Jan; 12(1):195-202. PubMed ID: 33296597
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of novel marine oxasqualenoid yucatecone against Naegleria fowleri.
Arberas-Jiménez I; Cen-Pacheco F; Chao-Pellicer J; Sifaoui I; Rizo-Liendo A; Morales EQ; Daranas AH; Díaz-Marrero AR; Piñero JE; Fernández JJ; Lorenzo-Morales J
Int J Parasitol Drugs Drug Resist; 2023 Aug; 22():61-71. PubMed ID: 37270868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
